Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract
1TissueTech, Inc and the Ocular Surface Center, Miami, Florida 33173, USA.
Purpose:
Macrophages play a pivotal role in initiating, maintaining, and resolving host inflammatory/immune responses but may cause recalcitrant inflammation and tissue damage if not controlled. Clinically, amniotic membrane (AM) transplantation suppresses inflammation in ocular surface reconstruction. Experimentally, the authors and others have reported that AM facilitates macrophage apoptosis. However, it remains unclear whether such anti-inflammatory activity is retained in AM extract (AME).
Methods:
Herein the authors demonstrate in resting and activated (by interferon [IFN]-gamma, lipopolysaccharide [LPS], or IFN-gamma/LPS) murine monocyte/macrophage RAW264.7 cells that AME suppresses cell spreading and reduces actin filaments determined by phalloidin staining and Western blotting of Triton X-100 extracted cell lysate.
Results:
Western blot and immunocytochemistry staining showed AME downregulates the expression of such cell surface markers as CD80, CD86, and major histocompatibility complex class 2 antigen. Cell growth/viability is inhibited whereas cell apoptosis is enhanced by AME. Accordingly, secreted proinflammatory cytokines such as TNF-alpha and IL-6 are reduced, but anti-inflammatory cytokine IL-10 is upregulated.
Conclusions:
Collectively, these results suggest that, similar to amniotic membrane, AME retains anti-inflammatory activities and does so by downregulating activation and inducing apoptosis in macrophages.
Insights
Amniotic membrane extract (AME) reduces macrophage activation and promotes apoptosis, retaining the anti-inflammatory properties of amniotic membrane. This suggests AME can help control inflammation and prevent tissue damage.
Area of Science:
- Immunology
- Cell Biology
- Tissue Engineering
Background:
- Macrophages are key immune cells involved in inflammation, but uncontrolled activity can lead to tissue damage.
- Amniotic membrane transplantation is clinically used to reduce ocular inflammation.
- Previous studies suggest amniotic membrane induces macrophage apoptosis, but its extract's activity is unknown.
Purpose of the Study:
- To investigate the anti-inflammatory potential of amniotic membrane extract (AME) on macrophages.
- To determine if AME retains the macrophage-modulating properties of amniotic membrane.
Main Methods:
- Murine macrophage cell line RAW264.7 were treated with AME.
- Cells were activated with interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS).
- Assessed cell morphology, actin filament content, cell surface marker expression, proliferation, apoptosis, and cytokine secretion.
Main Results:
- AME suppressed macrophage spreading and reduced actin filaments.
- AME downregulated key activation markers (CD80, CD86, MHC class 2) and inhibited cell growth.
- AME enhanced macrophage apoptosis and modulated cytokine profiles, reducing TNF-alpha and IL-6 while increasing IL-10.
Conclusions:
- Amniotic membrane extract (AME) exhibits significant anti-inflammatory effects on macrophages.
- AME suppresses macrophage activation and induces apoptosis, mirroring the effects of the amniotic membrane.
- AME holds potential for managing inflammatory conditions by modulating macrophage behavior.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

